Edwards Lifesciences (EW)

• Market cap: $44.7B
• 1 day: 2.96%
• 5 days: -0.68%
• 1 month: -4.43%
• 3 months: -6.85%
• 6 months: 1.5%
• Year to date: -7.03%
• 1 year: 11.87%
• 5 years: -9.92%
• 10 years: 201.06%
• Sector: Healthcare
• Industry: Medical Devices

About: Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter aortic valves, and transcatheter mitral and tricuspid valve technologies. The firm derives about 60% of its total sales from outside the US.

Employees: 15,800